PharmaResearch Co. defended its spin-off plan, stating the split ratio was set through expert review to minimize tax and legal risks, while pledging equal shareholder rights and transparency amid market concerns over governance and valuation.
#YonhapInfomax #PharmaResearch #SpinOff #ShareholderRights #TaxRisks #MarketCapitalization #Economics #FinancialMarkets #Banking #Securities #Bonds #StockMarket
https://en.infomaxai.com/news/articleView.html?idxno=68782